Author/Authors :
Jamil, Ayesha Azra Naheed Medical College - Department of Dermatology, Pakistan , Ahsan, Uzma Sharif Medical and Dental College - Department of Dermatology, Pakistan , Ahsan, Uzma Jinnah Hospital - Department of Dermatology, Unit-1, Pakistan , Malik, Lamees Mahmood Sharif Medical and Dental College - Department of Dermatology, Pakistan , Malik, Lamees Mahmood Jinnah Hospital - Department of Dermatology, Unit-1, Pakistan , Azfar, Nadia Ali Sharif Medical and Dental College - Department of Dermatology, Pakistan , Azfar, Nadia Ali Jinnah Hospital - Department of Dermatology, Unit-1, Pakistan , Jahangir, Muhammad Sharif Medical and Dental College - Department of Dermatology, Pakistan , Jahangir, Muhammad Jinnah Hospital - Department of Dermatology, Unit-1, Pakistan
Abstract :
Objective: To determine the frequency of dyslipidaemia in psoriatic patients. Methods: A cross-sectional study was carried out in the Department of Dermatology, Jinnah hospital, Lahore for the duration of six months. A total of 120 patients suffering from psoriasis, of any severity, belonging to either sex and with age between 15-70 years were included in the study. All patients in the study were investigated for total cholesterol, triglycerides, low-density lipoproteins and high-density lipoproteins after 12-14 hours of overnight fasting. Results: The mean age of the patients was 38.59 ± 13.86 years. There were 78 (65%) male and 42 (35%) female patients. The mean duration of psoriasis was 5.46 ± 4.49 years. The mean PASI score was 14.98 ± 8.95. There were 67 (55.8%) patients having dyslipidaemia and 53 (44.2%) patients had normal lipid levels. 34 (28.3%) patients had raised total cholesterol ( 200mg/dl), 32 (26.7%) raised low-density lipoprotein-cholesterol ( 130 mg/dl), 44 (36.7%) hypertriglyceridemia ( 150mg/dl) and 35 (29.2%) patients had reduced high-density lipoprotein-cholesterol levels ( 40mg/dl). Conclusion: It is concluded from this study that patients of psoriasis have a high incidence of dyslipidaemia, as it was found in 55.8% of psoriatic patients.